- Home
- Publications
- Publication Search
- Publication Details
Title
The Coming of Age of the P2X7 Receptor in Diagnostic Medicine
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 11, Pages 9465
Publisher
MDPI AG
Online
2023-05-30
DOI
10.3390/ijms24119465
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Spotlight on P2X7 Receptor PET Imaging: A Bright Target or a Failing Star?
- (2023) Stephan Schmidt et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Humoral Innate Immunity and Acute-Phase Proteins
- (2023) Alberto Mantovani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emerging PET Tracers in Cardiac Molecular Imaging
- (2023) Shashi Bhushan Singh et al. Cardiology and Therapy
- The shed P2X7 receptor is an index of adverse clinical outcome in COVID-19 patients
- (2023) Valentina Vultaggio-Poma et al. Frontiers in Immunology
- Role of LL-37 in thrombotic complications in patients with COVID-19
- (2022) Zilei Duan et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- High levels of extracellular ATP lead to different inflammatory responses in COVID-19 patients according to the severity
- (2022) Gilnei Bruno da Silva et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Beyond monoamines: I. Novel targets and radiotracers for Positron emission tomography imaging in psychiatric disorders
- (2022) Brian J. Lopresti et al. JOURNAL OF NEUROCHEMISTRY
- Extracellular ATP and Imbalance of CD4+ T Cell Compartment in Pediatric COVID-19
- (2022) Constanza Russo et al. Frontiers in Cellular and Infection Microbiology
- Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity
- (2022) Julio García-Villalba et al. Frontiers in Immunology
- Development and clinical translation of P2X7 receptor antagonists: A potential therapeutic target in coronary artery disease?
- (2022) Elijah Genetzakis et al. PHARMACOLOGY & THERAPEUTICS
- Positron Emission Tomography of Neuroimmune Responses in Humans: Insights and Intricacies
- (2022) Nakul R. Raval et al. SEMINARS IN NUCLEAR MEDICINE
- PET Imaging of P2X7 Receptor (P2X7R) for Neuroinflammation with Improved Radiosynthesis of Tracer [18F]4A in Mice and Non-human Primates
- (2022) Guolong Huang et al. ACS Chemical Neuroscience
- Increased uptake of the P2X7 receptor radiotracer 18 F‐JNJ ‐64413739 in the brain and peripheral organs according to the severity of status epilepticus in male mice
- (2022) James Morgan et al. EPILEPSIA
- Microglia dynamics in aging-related neurobehavioral and neuroinflammatory diseases
- (2022) Nima Javanmehr et al. Journal of Neuroinflammation
- Extracellular ATP: A powerful inflammatory mediator in the central nervous system
- (2022) Francesco Di Virgilio et al. NEUROPHARMACOLOGY
- More than a drug target: Purinergic signalling as a source for diagnostic tools in epilepsy
- (2022) Zheng Wei Wong et al. NEUROPHARMACOLOGY
- COVID ‐19: immunopathology, pathophysiological mechanisms, and treatment options
- (2021) Larissa E. Eijk et al. JOURNAL OF PATHOLOGY
- Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer
- (2021) Matthew Drill et al. Purinergic Signalling
- P2X7 Receptors in Neurodegeneration: Potential Therapeutic Applications From Basic to Clinical Approaches
- (2021) Paul R. Territo et al. Frontiers in Cellular Neuroscience
- Neuroinflammation in Major Depressive Disorder: A Review of PET Imaging Studies Examining the 18-kDa Translocator Protein
- (2021) Davide Gritti et al. JOURNAL OF AFFECTIVE DISORDERS
- Circulating P2X7 Receptor Signaling Components as Diagnostic Biomarkers for Temporal Lobe Epilepsy
- (2021) Giorgia Conte et al. Cells
- The P2X7 Receptor in Tumor Immunity
- (2021) Fabio Grassi et al. Frontiers in Cell and Developmental Biology
- Purinergic signaling, DAMPs, and inflammation
- (2020) Francesco Di Virgilio et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- A rationale for targeting the P2X7 receptor in Coronavirus disease 19 (Covid‐19)
- (2020) Francesco Di Virgilio et al. BRITISH JOURNAL OF PHARMACOLOGY
- P2X7 receptor antagonism preserves retinal ganglion cells in glaucomatous mice
- (2020) Giovanni Luca Romano et al. BIOCHEMICAL PHARMACOLOGY
- P2X7 in Cancer: From Molecular Mechanisms to Therapeutics
- (2020) Romain Lara et al. Frontiers in Pharmacology
- Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
- (2020) Deidiane Elisa Ribeiro et al. MOLECULAR PSYCHIATRY
- P2X7 Radioligand 18F-PTTP for the Differentiation of Lung Tumor and Inflammation
- (2019) Zhequan Fu et al. JOURNAL OF NUCLEAR MEDICINE
- Pharmacological blockade of the P2X7 receptor reverses retinal damage in a rat model of type 1 diabetes
- (2019) Carmen Clapp et al. ACTA DIABETOLOGICA
- [11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson’s disease and healthy volunteers
- (2019) Donatienne Van Weehaeghe et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The P2X7 Receptor Is Shed Into Circulation: Correlation With C-Reactive Protein Levels
- (2019) Anna Lisa Giuliani et al. Frontiers in Immunology
- The P2X7 receptor tracer [11C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study
- (2019) Marloes H. J. Hagens et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Chronic inflammation in the etiology of disease across the life span
- (2019) David Furman et al. NATURE MEDICINE
- Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [ 18 F]IUR-1601
- (2018) Mingzhang Gao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- PET Imaging of Microglial Activation—Beyond Targeting TSPO
- (2018) Bieneke Janssen et al. MOLECULES
- P2RX7 Purinoceptor as a Therapeutic Target—The Second Coming?
- (2018) Chris N. J. Young et al. Frontiers in Chemistry
- 18F-JNJ-64413739, a novel PET ligand for the P2X7 ion channel: radiation dosimetry, kinetic modeling, test-retest variability and occupancy of the P2X7 antagonist JNJ-54175446
- (2018) Michel Koole et al. JOURNAL OF NUCLEAR MEDICINE
- ATP in the tumour microenvironment drives expression of nfP2X7, a key mediator of cancer cell survival
- (2018) SM Gilbert et al. ONCOGENE
- The P2X7 Receptor in Infection and Inflammation
- (2017) Francesco Di Virgilio et al. IMMUNITY
- Design, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel 18F-labelled PET tracer targeting P2X7
- (2017) Enrico Raffaele Fantoni et al. EJNMMI Research
- Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates
- (2016) D. Ory et al. JOURNAL OF NUCLEAR MEDICINE
- 11 C-ER176, a Radioligand for 18-kDa Translocator Protein, Has Adequate Sensitivity to Robustly Image All Three Affinity Genotypes in Human Brain
- (2016) Masamichi Ikawa et al. JOURNAL OF NUCLEAR MEDICINE
- Synthesis of [11C]GSK1482160 as a new PET agent for targeting P2X7 receptor
- (2015) Mingzhang Gao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity
- (2014) B. J. Fowler et al. SCIENCE
- miR-150 Promotes Human Breast Cancer Growth and Malignant Behavior by Targeting the Pro-Apoptotic Purinergic P2X7 Receptor
- (2013) Songyin Huang et al. PLoS One
- A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases
- (2011) Nishkantha Arulkumaran et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The human P2X7 receptor and its role in innate immunity
- (2011) J. S. Wiley et al. TISSUE ANTIGENS
- P2X7 receptor expression is decreased in epithelial cancer cells of ectodermal, uro-genital sinus, and distal paramesonephric duct origin
- (2009) Xin Li et al. Purinergic Signalling
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started